Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 14/20 | 0.44 |
| ▸ | MMP1 | P03956 | 13/20 | 0.44 |
| ▸ | MMP9 | P14780 | 12/20 | 0.44 |
| ▸ | ADAM17 | P78536 | 7/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.42 |
| ▸ | MMP3 | P08254 | 2/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.41 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | MMP7 | P09237 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7544831 | 0.90 | TBXAS1 (0.45) | MMP13MMP1MMP9TBXAS1MMP3 | |
| SCHEMBL6129929 | 0.88 | MMP9 (0.54) | MMP13MMP1MMP9ADAM17MMP3 | |
| SCHEMBL7444896 | 0.85 | MMP13 (0.55) | MMP13MMP1MMP9ADAM17TBXAS1 | |
| SCHEMBL7439019 | 0.84 | MMP9 (0.57) | MMP13MMP1MMP9ADAM17 | |
| SCHEMBL7505208 | 0.83 | MMP13 (0.52) | MMP13MMP1MMP9ADAM17TBXAS1 | |
| SCHEMBL7447930 | 0.82 | MMP9 (0.50) | MMP13MMP1MMP9ADAM17 | |
| SCHEMBL7453108 | 0.82 | MMP1 (0.45) | MMP13MMP1MMP9ADAM17TBXAS1 | |
| SCHEMBL7453144 | 0.81 | MMP9 (0.56) | MMP13MMP1MMP9ADAM17 | |
| SCHEMBL7451360 | 0.81 | MMP9 (0.48) | MMP13MMP1MMP9ADAM17TBXAS1 | |
| SCHEMBL7510775 | 0.80 | MMP1 (0.47) | MMP13MMP1MMP9ADAM17TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0938471-B1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID CO (US) | 2001-12-12 | — | — | EP | claimed |
| EP-0938471-A1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | American Cyanamid Company (US) | 1999-09-01 | — | — | EP | claimed |
| WO-1998016503-A2 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1998-04-23 | — | — | WO | claimed |
| EP-0938471-B1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID CO (US) | 2001-12-12 | — | — | EP | disclosed |
| EP-0938471-A1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | American Cyanamid Company (US) | 1999-09-01 | — | — | EP | disclosed |
| WO-1998016503-A2 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1998-04-23 | — | — | WO | disclosed |